CO7061067A2 - Métodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas - Google Patents
Métodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinasInfo
- Publication number
- CO7061067A2 CO7061067A2 CO14072652A CO14072652A CO7061067A2 CO 7061067 A2 CO7061067 A2 CO 7061067A2 CO 14072652 A CO14072652 A CO 14072652A CO 14072652 A CO14072652 A CO 14072652A CO 7061067 A2 CO7061067 A2 CO 7061067A2
- Authority
- CO
- Colombia
- Prior art keywords
- aminopyridines
- sensory
- stroke
- treatment
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161543150P | 2011-10-04 | 2011-10-04 | |
US201261591833P | 2012-01-27 | 2012-01-27 | |
US201261648695P | 2012-05-18 | 2012-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7061067A2 true CO7061067A2 (es) | 2014-09-19 |
Family
ID=47143280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO14072652A CO7061067A2 (es) | 2011-10-04 | 2014-04-04 | Métodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas |
Country Status (21)
Country | Link |
---|---|
US (2) | US20130085167A1 (es) |
EP (1) | EP2766017B1 (es) |
JP (1) | JP6134722B2 (es) |
KR (1) | KR20140084120A (es) |
CN (2) | CN108451953A (es) |
AR (1) | AR088764A1 (es) |
AU (2) | AU2012318719B2 (es) |
BR (1) | BR112014008082A8 (es) |
CA (1) | CA2850635A1 (es) |
CL (1) | CL2014000799A1 (es) |
CO (1) | CO7061067A2 (es) |
CR (1) | CR20140153A (es) |
EA (1) | EA029558B1 (es) |
HK (2) | HK1201204A1 (es) |
IL (1) | IL231809B (es) |
MX (1) | MX354667B (es) |
SG (2) | SG10201600410SA (es) |
TW (1) | TWI592156B (es) |
UA (1) | UA114486C2 (es) |
WO (1) | WO2013052575A1 (es) |
ZA (1) | ZA201402432B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016517856A (ja) * | 2013-04-15 | 2016-06-20 | アコルダ セラピュティクス,インコーポレイテッド | アミノピリジンを使用した、ある種の卒中に関連した感覚運動障害を治療するための方法 |
US10172842B2 (en) | 2015-09-11 | 2019-01-08 | PharmaDax Inc. | Sustained release oral dosage form containing dalfampridine |
DE102017115701B4 (de) * | 2017-07-12 | 2022-03-03 | Lts Lohmann Therapie-Systeme Ag | Fampridin-TTS |
CN109172573B (zh) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | 一种口服抗血栓药物及其用途 |
CN115018836A (zh) * | 2022-08-08 | 2022-09-06 | 四川大学 | 一种癫痫病灶自动分割与预测方法、***及设备 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0696575B2 (ja) * | 1987-09-17 | 1994-11-30 | 三菱化成株式会社 | 4−アミノピリジン誘導体及びその酸付加塩 |
WO1989009600A1 (en) | 1988-04-08 | 1989-10-19 | Massachusetts Institute Of Technology | Method and composition for treating neurological disorders |
IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
CA2085785C (en) * | 1992-12-18 | 2005-03-15 | Robert R. Hansebout | The use of 4-aminopyridine in the treatment of a neurological condition |
US5952357A (en) | 1993-12-23 | 1999-09-14 | Cornell Research Foundation, Inc. | Treating diseases of the anterior horn cells |
AU3360000A (en) * | 1999-02-09 | 2000-08-29 | Uab Research Foundation | Use of 4-amino pyridine for treatment of peripheral neuropathies |
FR2791571B1 (fr) * | 1999-04-02 | 2002-10-04 | Sod Conseils Rech Applic | Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s) |
WO2001072335A2 (en) * | 2000-03-28 | 2001-10-04 | Queen's University At Kingston | Methods for effecting neuroprotection using a potassium channel modulator |
GB0119435D0 (en) * | 2001-02-15 | 2001-10-03 | Aventis Pharm Prod Inc | Method of treating of demyelinating diseases or conditions |
US8007826B2 (en) | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
US8354437B2 (en) | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
WO2008092167A2 (en) * | 2007-01-26 | 2008-07-31 | Safenet, Inc. | Protecting secrets in an untrusted recipient |
CA2825810A1 (en) * | 2011-01-28 | 2012-08-02 | Acorda Therapeutics, Inc. | Use of 4-aminopyridine to treat cerebral palsy |
-
2012
- 2012-10-03 TW TW101136564A patent/TWI592156B/zh not_active IP Right Cessation
- 2012-10-04 SG SG10201600410SA patent/SG10201600410SA/en unknown
- 2012-10-04 MX MX2014003997A patent/MX354667B/es active IP Right Grant
- 2012-10-04 EP EP12781519.9A patent/EP2766017B1/en active Active
- 2012-10-04 CN CN201810257441.8A patent/CN108451953A/zh active Pending
- 2012-10-04 JP JP2014534667A patent/JP6134722B2/ja not_active Expired - Fee Related
- 2012-10-04 CA CA2850635A patent/CA2850635A1/en not_active Abandoned
- 2012-10-04 BR BR112014008082A patent/BR112014008082A8/pt not_active Application Discontinuation
- 2012-10-04 KR KR1020147012028A patent/KR20140084120A/ko not_active Application Discontinuation
- 2012-10-04 SG SG11201401248YA patent/SG11201401248YA/en unknown
- 2012-10-04 US US13/644,990 patent/US20130085167A1/en not_active Abandoned
- 2012-10-04 AU AU2012318719A patent/AU2012318719B2/en not_active Ceased
- 2012-10-04 AR ARP120103710A patent/AR088764A1/es unknown
- 2012-10-04 CN CN201280059695.XA patent/CN104220072B/zh active Active
- 2012-10-04 EA EA201490562A patent/EA029558B1/ru not_active IP Right Cessation
- 2012-10-04 UA UAA201403422A patent/UA114486C2/uk unknown
- 2012-10-04 WO PCT/US2012/058607 patent/WO2013052575A1/en active Application Filing
-
2014
- 2014-03-30 IL IL231809A patent/IL231809B/en active IP Right Grant
- 2014-04-02 ZA ZA2014/02432A patent/ZA201402432B/en unknown
- 2014-04-02 CL CL2014000799A patent/CL2014000799A1/es unknown
- 2014-04-04 CR CR20140153A patent/CR20140153A/es unknown
- 2014-04-04 CO CO14072652A patent/CO7061067A2/es not_active Application Discontinuation
-
2015
- 2015-02-23 HK HK15101829.8A patent/HK1201204A1/xx unknown
- 2015-06-17 HK HK15105745.0A patent/HK1204965A1/xx not_active IP Right Cessation
- 2015-09-08 US US14/848,324 patent/US20160067232A1/en not_active Abandoned
-
2018
- 2018-01-05 AU AU2018200114A patent/AU2018200114A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20140034A (es) | Métodos para tratar el cáncer por el uso de antagonistas de unión al eje pd-1e inhibidores de mek | |
BR112016011983A2 (pt) | Painel, painel laminado, arranjo de painel, método para produzir o painel e uso do painel | |
CL2014001795A1 (es) | Dispositivo de carbonatacion y metodo de carbonatacion mediante el uso de dicho dispositivo | |
CO6930366A2 (es) | Método para el tratamiento de vhc | |
CO6821893A2 (es) | Uso del anticuerpo anti-cd19 inmunoconjugado con maitansinoide para el tratamiento del síntoma tumores de células b | |
BR112015027657A2 (pt) | Aparelho para uso com ferramentas eletromecânicas | |
CO6791602A2 (es) | Métodos y sistemas para el tratamiento de pozos | |
BR112015002091A2 (pt) | método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição | |
CO6821964A2 (es) | Compuestos para el tratamiento de la adicción | |
CO6920293A2 (es) | Compuestos antibaterianos y método para su uso | |
SMT201500057B (it) | Uso della biotina per il trattamento della sclerosi multipla | |
BR112013034055A2 (pt) | alcaftadina para uso no tratamento de urticária | |
DK2505748T3 (da) | Låsecylinder | |
CO7061067A2 (es) | Métodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas | |
DK2807170T3 (da) | Phragmalin-limonoider til behandlingen af seksuel dysfunktion | |
BR112013030248A2 (pt) | aeronave | |
BR112013030061A2 (pt) | aparelho para fabricação de ladrilhos | |
BR112013027627A2 (pt) | processo contínuo para produzir um perfil, perfil, uso de um perfil, e, aparelho para realizar o processo | |
CL2014003400A1 (es) | Espuma de cemento autoendurecible; cañon de espuma; dispositivo para la fabricacion de dicha espuma; y procedimiento para la fabricacion de dicha espuma. | |
BR112013023039A2 (pt) | dispositivos de trava para uso com atuadores rotativos | |
BR112013033892A2 (pt) | método para produzir um elastômero com enchedor, elastômero com enchedor, e, uso de um elastômero com enchedor | |
CL2014002480A1 (es) | Método para reducir el uso de antiespumante de silicona en procesos de coquizacion retardada | |
CO6880061A2 (es) | Método para tratar el cáncer mediante el uso combinado de fármacos | |
CR20130362A (es) | Método para el control de hongos fitopatógenos | |
BR112013022474A2 (pt) | aparelho de derivação para tanque de absorção |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |